Filter
63
Text search:
Multi-drugresistant
Tuberculosis/MDR-TB
Featured
Recommendations
16
New Publications
32
Language
Document type
No document type
51
Guidelines
7
Studies & Reports
2
Situation Updates
1
Strategic & Response Plan
1
Fact sheets
1
Countries / Regions
India
6
Kenya
4
Ethiopia
3
South Africa
3
Mozambique
3
Zambia
2
Bangladesh
2
South–East Asia Region
2
Uganda
1
Nepal
1
Germany
1
Tanzania
1
Namibia
1
Eswatini/ Swaziland
1
Ukraine
1
Colombia
1
Botswana
1
Lesotho
1
Myanmar / Burma
1
Paraguay
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
34
Clinical Guidelines
18
Public Health
4
Capacity Building
1
Toolboxes
TB
37
AMR
3
Refugee
2
Pharmacy
1
NTDs
1
National Tuberculosis and Leprosy Conrol Programme
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
For full publication see: https://drtbnetwork.org/mdr-tb-patient-education-flipchart
This tool can be used to educate new patients about TB and MDR-TB. The healthcare provider should review the material together with the patient. A treatment supporter can also use this flipchart at community lev
...
Accessed November 2017
6th edition
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release
...
This core package of materials provides a comprehensive introduction to the FAST strategy: a focused approach to stopping TB spread in congregate settings. In English, FAST stands for:
Finding TB cases
Actively,
Separating safely, and
Treating effectively.
FAST focuses health care w
...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
For full publication see: https://drtbnetwork.org/tracking-tool-tb-patients-who-meet-criteria-be-screened-mdr-tb
This tracking tool is intended to ensure appropriate microbiologic screening for all potential suspects who meet local criteria for evaluation of MDR-TB. This tool will assist in ident
...
